Deutsche Bank Ag\ Essa Pharma Inc. Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$7.8 - $14.38 $340,867 - $628,420	-43,701 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$7.76 - $29.37 $326,990 - $1.24 Million	42,138 Added 2695.97%	43,701 $350,000
Q2 2021 Aug 11, 2021	BUY	$24.17 - $34.28 $37,777 - $53,579	1,563 New	1,563 $45,000
Q1 2020 May 14, 2020	SELL	$3.23 - $5.87 $5,064 - $9,204	-1,568 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.05 - $6.0 $4,782 - $9,408	1,568 New	1,568 $8,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $72.3M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.